Gradually increasing levels of calcitonin in RET carriers reflects development of CCH, and calcitonin crossing upper ranges of normal is thought to be an early indicator of malignant transformation, although micro MTC was found in patients with normal calcitonin (Skinner et al. 1996). This evidence concerns the gene CALCA and columnar cell hyperplasia of the breast.